Simplex Trading’s Acer Therapeutics Inc ACER Stock Holding History

Simplex Trading’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,000	Closed	-$1K	–	10225
2023 Q3	$1K	Buy	2,000 +300	+18%	+$247	﹤0.01%	8491
2023 Q2	$1K	Sell	1,700 -4,000	-70%	-$3.54K	﹤0.01%	8802
2023 Q1	$4K	Buy	5,700 +2,400	+73%	+$4.73K	﹤0.01%	8250
2022 Q4	$8K	Buy	3,300 +1,000	+43%	+$1.72K	﹤0.01%	7776
2022 Q3	$3K	Sell	2,300 -1,500	-39%	-$2.17K	﹤0.01%	9189
2022 Q2	$4K	Buy	3,800 +1,500	+65%	+$3.14K	﹤0.01%	9071
2022 Q1	$6K	Sell	2,300 -3,200	-58%	-$7.72K	﹤0.01%	9357
2021 Q4	$12K	Buy	5,500 +3,600	+189%	+$8.36K	﹤0.01%	8898
2021 Q3	$5K	Hold	1,900	–	–	﹤0.01%	9310
2021 Q2	$5K	Buy	1,900 +1,726	+992%	+$4.97K	﹤0.01%	9495
2021 Q1	$54K	Buy	174 +122	+235%	+$415	﹤0.01%	6529
2020 Q4	$13K	Buy	+52	New	+$140	﹤0.01%	7277

Other funds holding ACER

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Simplex Trading's ACER Position: Q4 2023 in Review

Simplex Trading sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 1,945 shares — an estimated $1K sold.

Simplex Trading first reported a position in ACER in Q4 2020 and held it in 11 quarters. The position peaked at $51K in Q1 2021. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.

Simplex Trading reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
Simplex Trading sold 1,945 Acer Therapeutics Inc shares in Q4 2023, an estimated $1K.
Simplex Trading first reported a position in Acer Therapeutics Inc in Q4 2020 and held it in 11 quarters.
Simplex Trading's Acer Therapeutics Inc position peaked at $51K in Q1 2021.
2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.